Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.16 USD | +1.46% | -6.84% | +0.76% |
08/05 | Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M | MT |
08/05 | Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.76% | 1.58B | |
+11.98% | 9.08B | |
-10.76% | 5.06B | |
+53.60% | 4.85B | |
+7.56% | 3.85B | |
+14.09% | 2.37B | |
-21.42% | 2.36B | |
+25.03% | 2.27B | |
-30.36% | 2.22B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Supernus Pharmaceuticals : Jefferies Lifts Supernus Pharmaceuticals to Buy From Hold, Price Target to $40 From $25